C4 Therapeutics, Inc.·4

Sep 20, 4:13 PM ET

Adams Kendra 4

4 · C4 Therapeutics, Inc. · Filed Sep 20, 2024

Insider Transaction Report

Form 4
Period: 2024-09-18
Adams Kendra
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2024-09-18$6.38/sh1,837$11,72081,791 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the Reporting Person.

Documents

1 file
  • 4
    wk-form4_1726863223.xmlPrimary

    FORM 4